title: Vitamin D inhibition of the prostaglandin pathway as therapy for prostate cancer.
authors.affiliation: Department of Medicine/Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Room S-025, Stanford, CA 94305-5103, USA. feldman@cmgm.stanford.edu
authors.forename: David
authors.initials: D
authors.lastname: Feldman
authors.forename: Aruna
authors.initials: A
authors.lastname: Krishnan
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Moreno
authors.forename: Srilatha
authors.initials: S
authors.lastname: Swami
authors.forename: Donna M
authors.initials: DM
authors.lastname: Peehl
authors.forename: Sandy
authors.initials: S
authors.lastname: Srinivas
mesh_terms: D006801:Humans; D008297:Male; D011448:Prostaglandin Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D011453:Prostaglandins / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D014807:Vitamin D / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D014807:Vitamin D